Hjem › Spinal muskelatrofi
Kliniske studier for Spinal muskelatrofi rekrutterer i USA
23 studier for Spinal muskelatrofi rekrutterer deltakere på steder over hele USA.
Byer med flest studier
- Mountain View, CA9 studier
- New York City, NY9 studier
- Philadelphia, PA7 studier
- Chicago, IL6 studier
- Norfolk, VA6 studier
- Grand Rapids, MI6 studier
- Boston, MA5 studier
- Houston, TX5 studier
- Lewisville, TX4 studier
- Little Rock, AR4 studier
- Phoenix, AZ4 studier
- Aurora, CO4 studier
- Memphis, TN3 studier
- Durham, NC3 studier
- Orlando, FL3 studier
- Cedar Rapids, IA3 studier
- Columbia, MO3 studier
- Harrisburg, PA3 studier
- Charlottesville, VA3 studier
- Minneapolis, MN3 studier
- Portland, OR3 studier
- Fort Worth, TX3 studier
- Dallas, TX3 studier
- Gainesville, FL3 studier
- Atlanta, GA3 studier
- Orange, CA3 studier
Etter delstat
- Arizona4 studier
- Arkansas4 studier
- California11 studier
- Colorado4 studier
- Florida8 studier
- Georgia3 studier
- Illinois6 studier
- Iowa3 studier
- Massachusetts6 studier
- Michigan6 studier
- Minnesota3 studier
- Missouri4 studier
- New York10 studier
- North Carolina3 studier
- Oregon3 studier
- Pennsylvania8 studier
- Tennessee3 studier
- Texas10 studier
- Virginia7 studier
Nylig oppdaterte studier
Offisiell studietekst (engelsk)
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
RekruttererFase 4
3 Months – 24 Months · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05861986A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
RekruttererFase 2
Opp til 2 år · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07047144A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam
RekruttererFase 3
Alder 15 til 60 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07444476A Registry of Cases of Spinal Muscular Atrophy
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT07805278ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
RekruttererFase 4
Alder 2 til 100 · Alle kjønn · Oppdatert 18. sep. 2026 · NCT07448610A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
RekruttererFase 2
Alder 5 til 17 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07287982A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
RekruttererFase 4
3 Months – 24 Months · Alle kjønn · Oppdatert 10. sep. 2026 · NCT05861999A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
RekruttererFase 1
Alder 3 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06555419Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
Rekrutterer
Alder 18 til 80 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT07521930Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Rekrutterer
Alder 3 og eldre · Alle kjønn · Oppdatert 19. aug. 2026 · NCT05866419A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
RekruttererFase 3
0 Days – 42 Days · Alle kjønn · Oppdatert 18. aug. 2026 · NCT07221669A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
RekruttererFase 3
0 Days – 7 Months · Alle kjønn · Oppdatert 11. aug. 2026 · NCT07444450Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
RekruttererObservasjonsstudie
Alder 5 til 20 · Alle kjønn · Oppdatert 9. jul. 2026 · NCT06532474Clinical Procedures to Support Research in ALS
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 15. jun. 2026 · NCT03489278ALS/MND Natural History Study Data Repository
RekruttererObservasjonsstudie
Alder 18 til 90 · Alle kjønn · Oppdatert 20. mai 2026 · NCT05966038Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA
RekruttererObservasjonsstudie
Alder 12 og eldre · Alle kjønn · Oppdatert 14. mai 2026 · NCT06955897Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 5 og eldre · Alle kjønn · Oppdatert 9. apr. 2026 · NCT06839469HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness
Rekrutterer
Alder 5 til 17 · Alle kjønn · Oppdatert 23. mar. 2026 · NCT07488338Gait and Bone Health in SMA
RekruttererObservasjonsstudie
Alder 8 til 50 · Alle kjønn · Oppdatert 18. mar. 2026 · NCT07400198Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 17. mar. 2026 · NCT07478172A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies
RekruttererObservasjonsstudie
Alder 18 til 54 · Kvinner · Oppdatert 9. mar. 2026 · NCT05789758Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 16. jan. 2026 · NCT07223489Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 31. jan. 2025 · NCT04174157Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.